Engineered regulatory T (Treg) cells have emerged as precision therapeutics aimed at
inducing immune tolerance while reducing the risks associated with generalized …

Introduction: Immune tolerance remains the holy grail of therapeutic immunology in the fields
of organ and tissue transplant rejection, autoimmune diseases, and allergy and asthma. We …

Regulatory T cells (Tregs) are potent suppressors of immune responses and are currently
being clinically tested for their potential to stop or control undesired immune responses in …

Immune-suppressive cellular immunotherapy requires large numbers of antigen-specific
regulatory T cells (Treg cells), lymphocytes that suppress certain immune responses …

Regulatory Tcells (Treg) are essential components of peripheral immune homeostasis.
Adoptive Treg cell therapy has shown efficacy in a variety of immune-mediated diseases in …

Regulatory T cells (Treg cells) are a small subset of immune cells that are dedicated to
curbing excessive immune activation and maintaining immune homeostasis. Accordingly …

Regulatory T cells (Tregs) are an important subset of adaptive immune cells and control
immune reactions for maintaining homeostasis. Tregs are generated upon their encounter …

Cellular therapies using regulatory T (Treg) cells are currently undergoing clinical trials for
the treatment of autoimmune diseases, transplant rejection and graft-versus-host disease. In …

Regulatory T cells (Tregs) suppress exuberant immune system activation and promote
immunologic tolerance. Because Tregs modulate both innate and adaptive immunity, the …

Autoimmune disorders are long-term diseases that adversely affect the quality of life for
patients, and they are one of the top ten leading causes of death. While each autoimmune …